EATRIS offers a range of services to help researchers strengthen the translational potential of their research proposals:
Current Featured Open Calls:
1. ERA-NET TRANSCAN-3 Joint Transnational Call (JTC 2021) – NEXT GENERATION CANCER IMMUNOTHERAPY: TARGETING THE TUMOUR MICROENVIRONMENT (Pre-proposals deadline: June 29, 2021 – full proposal deadline: December 20, 2021)
TRANSCAN-3 aims at promoting highly innovative and ambitious collaborative projects in translational cancer research at European and international level, and considers that, based on the previous grounds, it is timely and relevant to foster the translation of new knowledge on TME functions into clinical practices. The expected impact of the call is to improve the efficacy of personalized treatment of cancer patients through the development of new tools and targeted immunotherapy strategies, based on a better understanding of TME functions and of their impact on the disease course.
- Aim 1: Identification and validation of TME subclasses and their contribution to the resistance mechanisms: Translational research using tumour samples collected from retrospective and/or prospective cohorts of patients
- Aim 2: Targeting TME to improve efficacy of immunotherapy in human patients.
The applicants are subject to eligibility criteria of national/regional funding organisations that have agreed to participate in JTC 2021. More information here.
2. MERCK 2021 RESEARCH GRANTS (deadline: August 31, 2021)
The aim of the Merck Research Grant is to create new sustainable partnerships with leading global science and technology players to work on breakthrough science and to generate valuable seeds for future business.
Merck KGaA, Darmstadt, Germany intends to offer research grants of 40,000-450,000 EUR/year for up to 3 years with an option to extend in the following research areas:
- Drug Discovery
- Real time testing and sensors
- Nanoparticle for nucleic acid delivery
- Digital Innovation
- Media recycling for cultured meat
The program is open to scientists at all career stages who are affiliated with any research-based institution, university or company. Applicants submit their application for the focus topics containing non-confidential information only. It is possible to apply for more than one grant or submit the application for more than one focus topic.
If the application is successful, applicants are invited to submit a full proposal under confidentiality and join a deep-dive workshop with the other finalists (in November and December 2021).
All applicants will be informed about the decision of the selection committee at the beginning of October 2021.
More information here.
3. Horizon Europe – European Innovation Council – Pathfinder Challenges (deadline: October 27, 2021)
EIC Pathfinder Challenges aim to build on new, cutting-edge directions in science and technology to disrupt a field and a market or create new opportunities by realizing innovative technological solutions grounded in high-risk/high-gain research and development.
The most relevant challenges for transnational research are the following:
- EIC Pathfinder Challenge – Emerging Technologies in Cell and Gene therapy
- EIC Pathfinder Challenge – Tools to measure and stimulate activity in brain tissue
For more information please look into EIC Work Programme 2021.
Please also see EATRIS’ institutions expertise for both challenges: Emerging Technologies in Cell and Gene therapy and Tools to measure and stimulate activity in brain tissue.
What can we help with?
1. FORMING A CONSORTIUM
EATRIS can help you find the right European academic partner for your consortium thanks to a comprehensive database of the high-end capabilities and expertise of 110 top-tier member institutions. This service is free of charge.If you are a member of the infrastructure, EATRIS can also support you in identifying companies, charities, or patient organisations for your consortium.
If you’re interested in this service, please fill in this form and send it to Anne-Charlotte Fauvel. Our team will provide you with a report listing the potential matches among EATRIS members within a few business days. It will then be your responsibility to liaise with the EATRIS institution or organisation of interest.
EATRIS is also a member of the Crowdhelix platform, and can also be contacted there for more information on specific expertise for open calls. If you are member too, EATRIS can interact with you on the opportunities posted.
2. JOINING AS A PARTNER
When relevant, EATRIS can participate in research funding proposals as full partner providing various centralised services with member institutions involved as linked third parties if necessary. EATRIS central coordination office based in Amsterdam can provide the following services:
2A) Innovation Management & industry partnering
Activities can include:
– Design of the dissemination and exploitation plan of the project;
– Definition and implementation of a monitoring plan to capture intellectual property protection needs;
– Identification of industry partnering opportunities for co-development and/or out-licensing;
– Follow-up financing opportunities.
Example: RECOGNISED project
2B) Regulatory support
EATRIS will leverage expertise from EATRIS affiliated institutions and perform dedicated tasks or work packages providing regulatory support by:
– Assessing the project’s regulatory strategy and feasibility;
– Interacting with the relevant regulatory authorities;
– Answering any regulatory question arising during the project’s lifetime;
– Ensuring the project fulfils all regulatory requirements.
Example: TRANSVAC-2 project
2C) Translational optimisation
Activities can include:
– Monitoring of the project to deliver a timely evaluation of the translational potential of the results generated during the project;
– Full translational assessment to definefollow-up validation route;
– Early HTA support.
2D) Training workshops
EATRIS can provide in-person workshops, tailor-made to the needs of your project, for example on:
– How to assess the translational potential of your project;
– How to develop collaboration with industry or;
– An introduction to translational medicine (particularly relevant for PhD students and postdocs). For more information, we invite you to download our workshops leaflet on our dedicated webpage.
– EATRIS also offers open access to an e-learning environment dedicated to translational research: TransMed Academy.
3. LETTER OF SUPPORT
EATRIS can provide coordinators with a letter of support for their proposal, provided the following criteria are met:
- The scope of the proposal must be translational and of high scientific quality;
- The proposal must be in line with EATRIS mission: “To support researchers in developing their biomedical discoveries into novel translational tools and interventions for better health outcomes for society”;
- The consortium must be multidisciplinary with laboratory and clinical expertise represented; and when relevant, industry and/or patient organisations included as partners;
- The consortium must include institutions leading in their field and/or close collaborators of EATRIS (academic members or strategic partners);
- The proposal must commit to compliance with FAIR principles and include data management plan as a project’s deliverable.
To request a letter of support, please send the latest draft of your proposal (or a 3-pager including the composition of the consortium, a summary of the concept and foreseen impact) a minimum of four weeks before proposal submission.
Note that we are bound by confidentiality rules and will not distribute any drafts or project summaries to others without your explicit permission or request.
4. LEADING FLAGSHIP PROJECTS
EATRIS may take a leading role in supporting the development and management of proposals coming from EATRIS member institutes. To be eligible for such support, the proposal has to be aligned with EATRIS Strategic Plan 2019-22.
Example: EU-PEARL led by Vall D’Hebron Research Institute, Head of the EATRIS Spanish node.